Diversified Healthcare Trust (DHC) is a REIT - Healthcare Facilities company in the Real Estate sector, currently trading at $7.31. It has a SharesGrow Score of 29/100, indicating a weak investment profile with 1 out of 7 criteria passed.
Analyst consensus target is DHC = $5 (-31.6% upside).
Valuation: DHC trades at a trailing Price-to-Earnings (P/E) of -6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.34.
Financials: revenue is $1.5B, +6.2%/yr average growth. Net income is $286M (loss), growing at -416.1%/yr. Net profit margin is -18.6% (negative). Gross margin is -16% (-29.6 pp trend).
Balance sheet: total debt is $2.4B against $1.7B equity (Debt-to-Equity (D/E) ratio 1.45, moderate). Current ratio is 100.72 (strong liquidity). Debt-to-assets is 55.4%. Total assets: $4.4B.
Analyst outlook: 3 / 17 analysts rate DHC as buy (18%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 63/100 (Pass), Growth 40/100 (Partial), Past 0/100 (Fail), Health 50/100 (Partial), Moat 24/100 (Fail), Future 16/100 (Fail), Income 10/100 (Fail).
